Stand Up and Do Something!
Individuals, patients, patient organisations, health professionals, researchers, drug developers, public health authorities - join this year's campaign!
Diabetes, obesity and hypertension increase mortality in hepatitis C patients

The specific impact of metabolic syndrome on mortality in hepatitis C patients was revealed by new research presented on Sunday April 26 at The International Liver Congress™ by EASL, the 2009 annual meeting of the European Association for the Study of the Liver in Copenhagen, Denmark.